Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Brain Behav Immun. 2020 May 5;88:193–202. doi: 10.1016/j.bbi.2020.05.013

Table 1.

Demographic and clinical variables of the study sample, and their relationship to the glucose-related composite score and peripheral inflammation as measured by plasma CRP.

Variable Mean (s.d.) (n=48) Correlation with Glucose Composite Score, r (p) Correlation with CRP, r (p)
Demographic and CRP
 Age (years) 38.3 (10.9) 0.314 (0.043) −0.086 (0.561)
 Sex, Male (n, %)
 Race
14 (29.2) 0.164 (0.301) 0.129 (0.382)
  Caucasian (n, %) 18 (37.5) −0.287 (0.065) −0.071 (0.629)
  African American (n, %) 30 (62.5)
 BMI (kg m−2) 31.3 (7.6) 0.426. (0.005) 0.619 (<0.001)
 CRP (mg/L)
Metabolic marker (n=42)
1.5 (1.6) 0.328 (0.034) -
 Glucose Composite Score 0.0 (2.43) - 0.328 (0.034)
 Glucose (mg/dL) 110.8 (19.6) 0.330 (0.033) −0.198 (0.208)
 Insulin (U/mL) 54.3 (34.4) 0.427 (0.005) 0.454 (0.003)
 Leptin (pg/mL) 13957.5 (5227.0) 0.521 (<0.001) 0.532 (<0.001)
 Adiponectin (ng/mL) 1272.7 (430.7) 0.554 (<0.001) −0.022 (0.891)
 Resistin (pg/mL) 2379.9 (2319.7) 0.652 (<0.001) 0.391 (0.01)

Abbreviations: BMI - Body Mass Index; CRP - C-reactive protein